Alexander Armstrong, Huong Ho, MBiostat Mark Tacey, Damien Bolton, Yee Chan, Alwin Tan, Chee Wee Cham, Trung Pham, Kevin McMillan, George Koufogiannis, Grad Dip, Paul Manohar, Mario Guerrieri, Michael Ng, Daryl Lim Joon, Farshad Foroudi, Mun Yee Tan, Michael Chao
PURPOSE: Low-dose-rate (LDR) brachytherapy in young men remains controversial amongst urologists due to their concerns regarding long-term biochemical control and treatment-related toxicities. The purpose of this study was to evaluate the treatment outcomes of men under 60 years of age who underwent LDR brachytherapy with iodine-125 (125 I) for clinically localized low- to intermediate-risk prostate cancer. MATERIAL AND METHODS: All consecutive patients with clinically localized prostate cancer treated at our institution from 2003 to 2016 with 125 I monotherapy were included in the study...
February 2024: Journal of Contemporary Brachytherapy